Monoclonal antibody production using a new supermacroporous cryogel bioreactor

Biotechnology Progress

Volumn 23, Issue 4, 2007, Pages 932-939

  Nilsang, Suthasinee ^a,b   Nandakumar, Kutty Selva ^c   Galaev, Igor Yu ^b   Rakshit, Sudip Kumar ^a   Holmdahl, Rikard ^c   Mattiasson, Bo ^b   Kumar, Ashok ^d  

^a ASIAN INSTITUTE OF TECHNOLOGY   (Thailand)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; HYBRIDOMA CELLS; LAG PHASE; SUPERMACROPOROUS CRYOGEL BIOREACTOR;

AMINO ACIDS; BIOREACTORS; CELL CULTURE; CELL GROWTH; COLLAGEN; GLUCOSE;

MONOCLONAL ANTIBODIES;

AMINO ACID; CRYOGEL; EPITOPE; FIBRONECTIN; GELATIN; GLUCOSE; LACTIC ACID DERIVATIVE; MONOCLONAL ANTIBODY; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTHRITIS; ARTICLE; BIOREACTOR; BIOTECHNOLOGY; CELL SURVIVAL; CHEMISTRY; HYBRIDOMA; INSTRUMENTATION; METABOLISM; METHODOLOGY; MOUSE; TUMOR CELL LINE;

AMINO ACIDS; ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS; BIOREACTORS; BIOTECHNOLOGY; BLOOD PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; EPITOPES; FIBRONECTINS; GELATIN; GLUCOSE; HYBRIDOMAS; LACTATES; MICE;

MUS;

EID: 34547876521     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0700399     Document Type: Article

References (59)

1. Köhler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256, 495-497.
2. Little, M.; Kipriyanov, S. M.; Le Gall, F.; Moldenhauer, G. Of mice and men: Hybridoma and recombinant antibodies. Immunol. Today 2000, 21, 364-370.
3. Werner, R. G. Economic aspects of commercial manufacture of biopharmaceuticals. J. Biotechnol. 2004, 113, 171-182.
4. Trebak, M.; Chong, J. M.; Herlyn, D.; Speicher, D. W. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. J. Immunol. Methods 1999, 230, 59-70.
5. Dong, H.; Tang, Y. J.; Ohashi, R.; Hamel, J. F. P. A Perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells. Biotechnol. Prog. 2005, 21, 140-147.
6. Stoll, T. S.; Chappaz, A.; Stockar, U.; Marison, I. W. Effects of culture conditions on the production and quality of monoclonal IgA. Enzyme Microb. Technol. 1997, 21, 203-211.
7. Iwahori, T.; Matsuno, N.; Johjima, Y.; Konno, O.; Akashi, I.; Nakamura, Y.; Hama, K.; Iwamoto, H.; Uchiyama, M.; Ashizawa, T.; Nagao, T. Radial flow bioreactor for the creation of bioarificial liver and kidney. Transplant Proc. 2005, 37, 212-214.
8. Pörtner, R.; Lüdemann, I.; Märkl, H. Dialysis cultures with immobilized hybridoma cells for effective production of monoclonal antibodies. Cytotechnology 1997, 23, 39-45.
9. Van der Pol, J. J.; Machnik, M.; Biselli, M.; Portela-Klein, T.; de Gooijer, C. D.; Tramper, J.; Wandrey, C. On-line immunoanalysis of monoclonal antibodies during continuous culture of hybridoma cells. Cytotechnology 1997, 24, 19-30.
10. Luo, J.; Yang, S. T. Effects of three-dimensional culturing in a fibrous matrix on cell cycle, apoptosis and mAb production by hybridoma cells. Biotechnol. Prog. 2004, 20, 306-315.
11. Zhu, H.; Yang, S. T. Long-term continuous production of monoclonal antibody by hybridoma cells immobilized in a fibrous-bed bioreactor. Cytotechnology 2004, 44, 1-14.
12. Curcio, E.; De Bartolo, L.; Barbieri, G.; Rende, M.; Giorno, L.; Morelli, S.; Drioli, E. Diffusive and convective transport through hollow fiber membranes for liver cell culture. J. Biotechnol. 2005, 117, 309-321.
13. Gramer, M. J.; Maas, J.; Lieberman, M. M. Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell cultured in CL-1000 flasks using BD Cell mAb medium. Cytotechnology 2003, 42, 155-162.
14. Jackson, L. R.; Trudel, L. J.; Fox, J. G.; Lipman, N. S. Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody. J. Immunol. Methods 1996, 189, 217-231.
15. Singh, V. Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 1999, 30, 149-158.
16. Tang, Y-J.; Ohashi, R.; Hamel, J. F. P. Perfusion culture of hybridoma cells for hyperproduction of IgG2a monoclonal antibody in a wave bioreactor-perfusion culture system. Biotechnol. Prog. 2007, 23, 255-264.
17. Li, X.; Liu, T.; Song, K.; Yao, L.; Ge, D.; Bao, C.; Ma, X.; Cui, Z. Culture of neural stem cells in calcium alginate beads. Biotechnol. Prog. 2006, 22, 1683-1689.
18. Yamaguchi, M.; Shirai, Y.; Inouye, Y.; Shoji, M.; Kamei, M.; Hashizyme, S.; Shirahata, S. Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles. Cytotechnology 1997, 23, 5-12.
19. Yang, S. T.; Luo, J.; Chen, C. A fibrous-bed bioreactor of continuous production of monoclonal antibody by hybridoma. Adv. Biochem. Eng./Biotechnol. 2004, 87, 61-96.
20. Xiao, C.; Huang, Z.; Li, W.; Hu, X.; Qu, W.; Gao, L.; Liu, G. High density and scale-up cultivation of recombinant CHO cell line and hybridomas with porous microcarrier Cytopore. Cytotechnology 1999, 30, 143-147.
21. Wu, S. C.; Hsieh, W. C.; Liau, M. Y. Comparisons of microcarrier cell culture processes in one hundred mini-liter spinner flask and fifteen-liter bioreactor cultures. Bioprocess Eng. 1998, 19, 431-434.
22. Kong, D.; Chen, M.; Gentz, R.; Zhang, J. Cell growth and protein formation on various microcarriers. Cytotechnology 1999, 29, 149-156.
23. Amstein, C. F.; Hartman, P. A. Adaptation of plastic surfaces for tissue culture by glow discharge. J. Clin. Microbiol. 1975, 46-54.
24. Lowrey, D.; Murphy, S.; Goffe, R. A. A comparison of monoclonal antibody productivity in different hollow fiber bioreactors. J. Biotechnol. 1994, 36, 35-38.
25. Heilmann, K.; Groth, Th.; Behrsing, O.; Albrecht, W.; Schossig, M.; Lendlein, A.; Micheel, B. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells. J. Biotechnol. 2005, 115, 291-301.
26. Arvidsson, P.; Plieva, F. M.; Savina, I. N.; Lozinsky, V. I.; Fexby, S.; Bülow, L.; Galaev, I. Yu.; Mattiasson, B. Chromatography of microbial cells using continuous supermacroporous affinity and ion exchange columns. J. Chromatogr., A. 2002, 977, 27-38.
27. Dainiak, M. B.; Plieva, F. M.; Galaev, I. Yu.; Hatti-Kaul, R.; Mattiasson, B. Cell Chromatography: Separation of different microbial cells using IMAC supermacroporous columns. Biotechnol. Prog. 2005, 21, 644-649.
28. Kumar, A.; Plieva, F. M.; Galaev, I. Yu.; Mattiasson, B. Affinity fractionation of lymphocytes using a monolithic cryogel. J. Immunol. Methods 2003, 283, 185-194.
29. Kumar, A.; Rodríguez-Caballero, A.; Plieva, F. M.; Galaev, I. Yu.; Nandakumar, K. S.; Kamihira, M.; Holmdahl, R.; Orfao, A.; Mattiasson, B. Affinity binding of cells to cryogels adsorbents with immobilized specific ligands: effect of ligand coupling and matrix architecture. J. Mol. Recognit. 2005, 18, 84-93.
30. Williams, S. L.; Eccleston, M. E.; Slater, N. K. H. Affinity capture of a biotinylated retrovirus on macroporous monolithic adsorbents: Towards a rapid single-step purification process. Biotechnol. Bioeng. 2005, 89, 783-787.
31. Kumar, A.; Bansal, V.; Nandakumar, K. S.; Galaev, I. Yu.; Roychoudhury, P. K.; Holmdahl, R.; Mattiasson, B. Integrated bioprocess for the production and isolation of urokinase from animal cell culture using supermacroporous cryogel matrices. Biotechnol. Bioeng. 2006, 93, 637-646.
32. Mo, J. A.; Holmdahl, R. The B cell response to autologous type II collagen: Biased V gene repertoire with V gene sharing and epitope shift. J. Immunol. 1996, 157, 2440-2448.
33. Holmdahl, R.; Rubin, K.; Klareskog, L.; Larsson, E.; Wigzell, H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 1986, 29, 400-410.
34. Nandakumar, K. S.; Andren, M.; Martinsson, P.; Bajtner, E.; Hellstrom, S.; Holmdahl, R.; Kleinau, S. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur. J. Immunol. 2003, 33, 2269-2277.
35. Nandakumar, K. S.; Backlund, J.; Vestberg, M.; Holmdahl, R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res. Ther. 2004, 6, R544-R550.
36. Hietala, M. A.; Nandakumar, K. S.; Persson, L.; Fahlen, S.; Holmdahl, R.; Pekna, M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur. J. Immunol. 2004, 34, 1208-1216.
37. Nandakumar, K. S.; Holmdahl, R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J. Immunol. Methods 2005, 304, 126-136.
38. Gray, R. E.; Seng, N.; Mackay, I. R.; Rowley, M. J. Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. J. Immunol. Methods 2004, 285, 55-61.
39. Amirahmadi, S. F.; Whittingham, S.; Crombie, D. E.; Nandakumar, K. S.; Holmdahl, R.; Mackay, I. R.; van Damme, M. P.; Rowley, M. J. Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells. Arthritis Rheum. 2005, 52, 1897-1906.
40. Worthington Enzymes, Enzyme Reagents and Related Biochemicals. Worthington Biochemical Corp.: Lakewood, NJ, 1972; p92.
41. Björnsson, L.; Murto, M.; Mattiasson, B. Evaluation of parameters for monitoring an anaerobic co-digestion process. Appl. Microbiol. Biotechnol. 2000, 54, 844-849.
42. Nandakumar, K. S.; Holmdahl, R. A genetic contamination in MHC-congenic mouse strains reveals a locus on chromosome 10 that determines autoimmunity and arthritis susceptibility. Eur. J. Immunol. 2005, 35, 1275-1282.
43. Holmdahl, R.; Carlsen, S.; Mikulowska, A.; Vestberg, M.; Brunsberg, U.; Hansson, A.-S.; Sundvall, M.; Jansson, L.; Pettersson, U. In Genetic Analysis of Mouse Models for Rheumatoid Arthritis; Adolph, K. W., Ed.; CRC Press: New York, 1998; pp 215-237.
44. Rodrigues, M. T. A.; Vilaça, P. R.; Garbuio, A.; Takagi, M.; Barbosa, S., Jr.; Léo, P.; Laignier, N. S.; Silva, A. A. P.; Moro, A. M. Glucose uptake rate as a tool to estimate hybridoma growth in a packed bed bioreactor. Bioprocess Eng. 1999, 21, 543-546.
45. Portner, R.; Bohmann, A.; Ludemann, I.; Markl, H. Estimation of specific glucose uptake rates in cultures of hybridoma cell. J. Biotechnol. 1994, 34, 237-246.
46. Legazpi, L.; D'iaz, J.; Laca, A.; D'iaz, M. Kinetic analysis of hybridoma cell culture in a protein-free medium: Substrate and agitation effects. Biochem. Eng. J. 2005, 26, 122-130.
47. Neermann, J.; Wagner, R. Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J. Cell. Physiol. 1996, 166, 152-169.
48. Banabé, N.; Butler, M. The effect of glucose and glutamine on the intracellular nucleotide pool and oxygen uptake rate of a murine hybridoma. Cytotechnology 2000, 34, 47-57.
49. Gaertner, J. G.; Dhurjati, P. Fractional factorial study of hybridoma behavior. 2. Kinetics of nutrient uptake and waste production. Biotechnol. Prog. 1993, 9, 309-316.
50. Ozturk, S. S.; Palsson, B. O. Growth, metabolic and antibody production kinetics of hybridoma cell culture. 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor. Biotechnol. Prog. 1991, 7, 481-494.
51. Sanfeliu, A.; Cairó, J.; Casas, C.; Solò, C.; Gòdia, F. Analysis of nutritional factors and physical conditions affecting growth and monoclonal antibody production of the hybridoma KB-26.5 cell line. Biotechnol. Prog. 1996, 12, 209-216.
52. Wang, D.; Liu, W.; Han, B.; Xu, R. The bioreactor: A powerful tool for large-scale culture of animal cells. Curr. Pharm. Biotechnol. 2005, 6, 397-403.
53. Matsumura, M.; Nayve, F.; Rey, P., Jr. Effects of ammonium ion removal on growth and mAb production of hybridoma cells. Cytotechnology 1995, 18, 35-50.
54. Chen, K.; Liu, Q.; Xie, L.; Sharp, P. A.; Wang, D. I. C. Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production. Biotechnol. Bioeng. 2001, 72, 55-61.
55. Chen, C.; Chen, K.; Yang, S. T. Effects of three dimensional culturing on osteosarcoma cells grown in a fibrous matrix: Analyses of cell morphology, cell cycle, and apoptosis. Biotechnol. Prog. 2003, 19, 1574-1582.
56. Nandakumar, K. S.; Svensson, L.; Holmdahl, R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: Description of the disease and the influence of age, sex, and genes. Am. J. Pathol. 2003, 163, 1827-1837.
57. Li, J.; Ny, A.; Leonardsson, G.; Nandakumar, K S.; Holmdahl, R.; Ny, T. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am. J. Pathol. 2005, 166, 783-792.
58. Nandakumar, K. S.; Holmdahl, R. Arthritis induced with cartilage-specific antibodies is IL-4-dependent. Eur. J. Immunol. 2006, 36, 1608-1618.
59. Johannesson, M.; Karlsson, J.; Wernhoff, P.; Nandakumar, K. S.; Lindqvist, A. K.; Olsson, L.; Cook, A. D.; Andersson, A.; Holmdahl, R. Identification of epistasis through a partial advanced intercross reveals three arthritis loci within the Cia5 QTL in mice. Genes Immun. 2005, 6, 175-85.